Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Executive Vice President | December 29, 2011 | December 21, 2012 |
| AbbVie Inc.ABBV · Entity 2800 | Director | March 31, 2025 | April 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 29, 2011 · Filed December 21, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 49,432 |
Reported balance
After 2011-12-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2011-12-29 · Gift · Disposed 24,982 · Balance 49,432 F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the transfer of 111,161 Abbott common shares that was exempt from Section 16.
AbbVie Inc.
Report date March 31, 2025 · Filed April 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 386,479 |
Reported balance
After 2025-03-31 transaction · row 1
1 source rowRow 1 · 2025-03-31 · Gift · Disposed 2,450 · Balance 386,479 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2006 Filed Apr 4, 2006 18:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,050 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-022078 · a4.xml · derivative · entry 7 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,050 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 31, 2006 Filed Apr 4, 2006 18:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 79,426 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-06-022078 · a4.xml · derivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 351,235 Underlying: common shares · 79,426 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 31, 2006 Filed Apr 4, 2006 18:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 570 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-06-022078 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,875 Read SEC document |
| March 31, 2006 Filed Apr 4, 2006 18:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 71,191 | $42.64 | $3,035,584.24 |
DisclosureSEC source: 0001104659-06-022078 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,445 Read SEC document |
| March 31, 2006 Filed Apr 4, 2006 18:42 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 82,476 | $33.23 | $2,740,792.95 |
DisclosureSEC source: 0001104659-06-022078 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2006 Filed Mar 29, 2006 20:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 25,000 | $43.92 | $1,098,000.00 |
DisclosureSEC source: 0001104659-06-020171 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 415,160 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 18, 2006 Filed Feb 22, 2006 23:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 6,102 | $44.15 | $269,403.30 |
DisclosureSEC source: 0001104659-06-011237 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,160 Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 23:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 310,000 | $0.00 Strike: $44.16 | $0.00 |
DisclosureSEC source: 0001104659-06-011237 · a4.xml · derivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,000 Underlying: common shares · 310,000 shares Expires 2016-02-16 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) Rule 16b-3. The option becomes exercisable in annual increments of 103,334 on 2/17/2007, 103,333 on 2/17/2008 and 103,333 on 2/17/2009. Read SEC document |
| February 17, 2006 Filed Feb 22, 2006 23:00 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 100,000 | $44.16 | $4,416,000.00 |
DisclosureSEC source: 0001104659-06-011237 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,160 F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 16,399 | $0.00 Strike: $38.42 | $0.00 |
DisclosureSEC source: 0001104659-06-005422 · a4.xml · derivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 16,399 shares Expires 2006-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 15,199 | $43.00 | $653,557.00 |
DisclosureSEC source: 0001104659-06-005422 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,262 Read SEC document |
| January 30, 2006 Filed Feb 1, 2006 23:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 16,399 | $38.42 | $630,034.82 |
DisclosureSEC source: 0001104659-06-005422 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,461 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 17, 2005 Filed Feb 1, 2006 23:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 325 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-06-005422 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,062 Read SEC document |
| November 01, 2005 Filed Nov 2, 2005 21:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,729 | $43.00 | $246,347.00 |
DisclosureSEC source: 0001104659-05-051947 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,387 Read SEC document |
| October 27, 2005 Filed Nov 2, 2005 21:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-051947 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,116 Read SEC document |
| August 01, 2005 Filed Aug 2, 2005 21:01 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 4,271 | $46.91 | $200,352.61 |
DisclosureSEC source: 0001104659-05-035725 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,366 Read SEC document |
| April 20, 2005 Filed May 17, 2005 20:41 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 1,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-024133 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,637 Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 37,256 | $0.00 Strike: $46.65 | $0.00 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · derivative · entry 14 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,256 Underlying: common shares · 37,256 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,142 | $0.00 Strike: $46.65 | $0.00 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · derivative · entry 13 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,142 Underlying: common shares · 2,142 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 2,142 | $0.00 Strike: $46.65 | $0.00 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · derivative · entry 12 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,142 Underlying: common shares · 2,142 shares Expires 2007-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 45,113 | $0.00 Strike: $33.23 | $0.00 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · derivative · entry 11 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 433,711 Underlying: common shares · 45,113 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 10,653 | $0.00 Strike: $39.98 | $0.00 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · derivative · entry 10 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 10,653 shares Expires 2005-04-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,065 | $0.00 Strike: $32.61 | $0.00 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · derivative · entry 9 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,065 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 3,643 | $0.00 Strike: $27.43 | $0.00 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · derivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,643 shares Expires 2007-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 51,270 | $46.65 | $2,391,745.50 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,604 Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 45,113 | $33.23 | $1,499,168.15 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,874 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 10,653 | $39.98 | $425,897.35 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,065 | $32.61 | $99,953.02 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,108 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2005 Filed Mar 11, 2005 00:03 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 3,643 | $27.43 | $99,937.69 |
DisclosureSEC source: 0001104659-05-010464 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,043 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 313,200 | $0.00 Strike: $46.34 | $0.00 |
DisclosureSEC source: 0001104659-05-008010 · a4.xml · derivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,200 Underlying: common shares · 313,200 shares Expires 2015-02-17 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 104,400 on 2/18/06, 104,400 on 2/18/07 and 104,400 on 2/18/08. Read SEC document |
| February 18, 2005 Filed Feb 23, 2005 22:49 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 46,400 | $46.34 | $2,150,176.00 |
DisclosureSEC source: 0001104659-05-008010 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,400 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| February 11, 2005 Filed Feb 14, 2005 21:08 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 4,197 | $45.77 | $192,096.69 |
DisclosureSEC source: 0001104659-05-006391 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,000 Read SEC document |
| December 22, 2004 Filed Feb 1, 2005 17:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-003427 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,197 Read SEC document |
| December 16, 2004 Filed Feb 1, 2005 17:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 412 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-003427 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,647 Read SEC document |
| November 15, 2004 Filed Feb 1, 2005 17:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 294 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-003427 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,059 Read SEC document |
| July 22, 2004 Filed Feb 1, 2005 17:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 275 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-003427 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,353 Read SEC document |
| May 05, 2004 Filed Feb 1, 2005 17:21 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 1,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-05-003427 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,628 Read SEC document |
| February 20, 2004 Filed Feb 24, 2004 21:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 270,000 | $0.00 Strike: $43.66 | $0.00 |
DisclosureSEC source: 0001104659-04-005599 · a4.xml · derivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,000 Underlying: common shares · 270,000 shares Expires 2014-02-19 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 1/3, 1/3, and 1/3 beginning on February 20, 2005, the first anniversary date of the grant. Read SEC document |
| February 20, 2004 Filed Feb 24, 2004 21:14 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 40,000 | $43.66 | $1,746,400.00 |
DisclosureSEC source: 0001104659-04-005599 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · President and COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,688 F1 · kind: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes. Read SEC document |
| January 26, 2004 Filed Jan 28, 2004 21:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 11,880 | $43.50 | $516,780.00 |
DisclosureSEC source: 0001104659-04-001974 · a4.xml · nonDerivative · entry 6 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,688 Read SEC document |
| December 24, 2003 Filed Jan 28, 2004 21:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 428 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-001974 · a4.xml · nonDerivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,568 Read SEC document |
| November 06, 2003 Filed Jan 28, 2004 21:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-001974 · a4.xml · nonDerivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,996 Read SEC document |
| November 05, 2003 Filed Jan 28, 2004 21:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 475 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-001974 · a4.xml · nonDerivative · entry 3 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,396 Read SEC document |
| November 03, 2003 Filed Jan 28, 2004 21:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 270 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-001974 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,871 Read SEC document |
| September 12, 2003 Filed Sep 16, 2003 18:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 23,776 | $0.00 Strike: $43.57 | $0.00 |
DisclosureSEC source: 0001104659-03-020784 · a4.xml · derivative · entry 5 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,776 Underlying: common shares · 23,776 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| September 12, 2003 Filed Sep 16, 2003 18:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 27,119 | $0.00 Strike: $34.70 | $0.00 |
DisclosureSEC source: 0001104659-03-020784 · a4.xml · derivative · entry 4 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,881 Underlying: common shares · 27,119 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2003 Filed Sep 16, 2003 18:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingcommon shares without par value | 23,776 | $43.57 | $1,035,920.32 |
DisclosureSEC source: 0001104659-03-020784 · a4.xml · nonDerivative · entry 2 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,087 Read SEC document |
| September 12, 2003 Filed Sep 16, 2003 18:45 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversioncommon shares without par value | 27,119 | $34.70 | $941,029.30 |
DisclosureSEC source: 0001104659-03-020784 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2003 Filed Jan 28, 2004 21:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 15,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-001974 · a4.xml · nonDerivative · entry 8 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 15,266 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife. Read SEC document |
| March 06, 2003 Filed Jan 28, 2004 21:35 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 15,946 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-04-001974 · a4.xml · nonDerivative · entry 1 GONZALEZ RICHARD A · CIK 0001239127 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,141 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.